Year-end Sale % OFF 
Abstract
Meyer Friedmann et al. (Lancet II: 464, 1971) reported that chronic administration of glucagon (2×500 μg/kg daily s.c. for a fortnight) strongly reduced the plasma cholesterol of normal rats (by about 40%) and prevented the development of experimental hypercholesterolemia. The present study confirms by dose-response curves in normal rats that “this hormone may be the most potent endogenous agent of the body in the regulation of plasma cholesterol”.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
